Although tumor-draining LNs have traditionally been regarded as immunocompromised sites that are not conducive for efficient anti-tumor immune responses [153,154], recent data has shown LN-resident CD8+ T cells efficiently delete metastatic tumor cells in a mouse melanoma model [155]. This evidence concerns the gene CD8A and neoplasm.